Synspira Therapeutics Announces Appointment of Robert Gallotto as President and Chief Executive Officer - PRNewswire

Synspira Therapeutics Announces Appointment of Robert Gallotto as President and Chief Executive Officer  PRNewswire

Synspira's lead product targeting cystic fibrosis and other pulmonary diseases, SNSP113, to enter Phase 2 Clinical Trials in Second Half of 2019 - ...